Literature DB >> 9770646

6-hydroxydopamine lesion of rat nigrostriatal dopaminergic neurons differentially affects nicotinic acetylcholine receptor subunit mRNA expression.

K J Elliott1, J M Jones, A I Sacaan, G K Lloyd, J Corey-Naeve.   

Abstract

Nicotinic acetylcholine receptor (nAChR) subunit mRNA expression in the rat substantia nigra (SN) was assayed by semiquantitative RT-PCR following 6-hydroxydopamine (6-OHDA) lesion of nigrostriatal dopaminergic neurons. Six months after unilateral injection of 6-OHDA or saline into the SN, total RNA was isolated from ipsilateral and contralateral tissue samples. RT-PCR amplifications were performed with template titration using primers specific for sequences encoding 1. nAChR alpha 2-alpha 7 and beta 2-beta 4 subunits 2. Glutamic acid decarboxylase 3. Glyceraldehyde 3-phosphate dehydrogenase for normalization of template mass. PCR products specific for alpha 3, alpha 4, alpha 5, alpha 6, alpha 7, beta 2, beta 3, and glutamic acid decarboxylase were detected in the reactions containing SN RNA. This is the first evidence that alpha 7 may be expressed in the SN. alpha 2 and beta 4 PCR products were not detected in SN reactions, although they were observed in hippocampus and thalamus control reactions. A comparison of ipsilateral and contralateral SN RT-PCR reaction products showed substantial decreases in alpha 5, alpha 6, and beta 3 product yields following 6-OHDA, but not sham treatment. Neither the SN of sham-lesioned rats nor the thalamus of 6-OHDA-lesioned rats yielded similar results, indicating that the effects observed in 6-OHDA-treated SN were not caused by local mechanical damage or a nonspecific response, respectively. Effects of 6-OHDA treatment on alpha 3, alpha 4, alpha 7, beta 2, or glutamic acid decarboxylase product yields from SN samples were small or undetectable. The results suggest that alpha 5, alpha 6, and beta 3 subunit-encoding mRNAs are expressed at substantially higher levels in dopaminergic than in nondopaminergic cell bodies in the SN.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9770646     DOI: 10.1007/BF02761778

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  36 in total

1.  The distribution of mRNA encoded by a new member of the neuronal nicotinic acetylcholine receptor gene family (alpha 5) in the rat central nervous system.

Authors:  E Wada; D McKinnon; S Heinemann; J Patrick; L W Swanson
Journal:  Brain Res       Date:  1990-08-27       Impact factor: 3.252

2.  Neuronal bungarotoxin blocks the nicotinic stimulation of endogenous dopamine release from rat striatum.

Authors:  D W Schulz; R E Zigmond
Journal:  Neurosci Lett       Date:  1989-04-10       Impact factor: 3.046

3.  Neurons assemble acetylcholine receptors with as many as three kinds of subunits while maintaining subunit segregation among receptor subtypes.

Authors:  A B Vernallis; W G Conroy; D K Berg
Journal:  Neuron       Date:  1993-03       Impact factor: 17.173

4.  Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions.

Authors:  W G Conroy; D K Berg
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

5.  Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease.

Authors:  I Nakano; A Hirano
Journal:  Ann Neurol       Date:  1984-05       Impact factor: 10.422

6.  Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors.

Authors:  C W Luetje; J Patrick
Journal:  J Neurosci       Date:  1991-03       Impact factor: 6.167

7.  Beta 3: a new member of nicotinic acetylcholine receptor gene family is expressed in brain.

Authors:  E S Deneris; J Boulter; L W Swanson; J Patrick; S Heinemann
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

8.  Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.

Authors:  P B Clarke; M Reuben
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

9.  Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat.

Authors:  E Wada; K Wada; J Boulter; E Deneris; S Heinemann; J Patrick; L W Swanson
Journal:  J Comp Neurol       Date:  1989-06-08       Impact factor: 3.215

10.  Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors.

Authors:  D S McGehee; M J Heath; S Gelber; P Devay; L W Role
Journal:  Science       Date:  1995-09-22       Impact factor: 47.728

View more
  6 in total

1.  Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice.

Authors:  R E Ryan; S A Ross; J Drago; R E Loiacono
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Developmental regulation of nicotinic acetylcholine receptors within midbrain dopamine neurons.

Authors:  L Azam; Y Chen; F M Leslie
Journal:  Neuroscience       Date:  2006-12-29       Impact factor: 3.590

Review 3.  Nervous and Neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesis.

Authors:  Marco Marzioni; Giammarco Fava; Antonio Benedetti
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

Review 4.  Control of cholangiocyte adaptive responses by visceral hormones and neuropeptides.

Authors:  Marco Marzioni; Giammarco Fava; Domenico Alvaro; Gianfranco Alpini; Antonio Benedetti
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

Review 5.  Nicotinic receptors as CNS targets for Parkinson's disease.

Authors:  Maryka Quik; Tanuja Bordia; Kathryn O'Leary
Journal:  Biochem Pharmacol       Date:  2007-06-17       Impact factor: 5.858

6.  Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei.

Authors:  R Klink; A de Kerchove d'Exaerde ; M Zoli; J P Changeux
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.